GLP-1 agonists, like semaglutide, are revolutionizing obesity treatment, potentially impacting millions. These medications work on the brain’s reward center, reducing addictive behaviors and cravings. A significant advancement in public health. #GLP1Agonists #ObesityTreatment #Semaglutide #PublicHealth #AddictionHelp
